Aymen Al-Shamkhani

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Transforming Growth Factor

Editorial Comment

Diffuse Large B Cell Lymphoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kirsty Ford, Christopher J Hanley, Massimiliano Mellone, Cedric Szyndralewiez, Freddy Heitz, Philippe Wiesel, Oliver Wood, Maria Machado, Maria-Antoinette Lopez, Anusha-Preethi Ganesan, Chuan Wang, Ankur Chakravarthy, Tim R Fenton, Emma V King, Pandurangan Vijayanand, Christian Hermann Ottensmeier, Aymen Al-Shamkhani, Natalia Savelyeva, Gareth J Thomas
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors. Cancer research 80 (9) (2020)
John R Ferdinand, Arianne C Richard, Françoise Meylan, Aymen Al-Shamkhani, Richard M Siegel
Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. Journal of immunology (Baltimore, Md. : 1950) 200 (4) (2018)
Sarah L Buchan, Anne Rogel, Aymen Al-Shamkhani
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood 131 (1) (2017)
Oanh H Pham, Hope O'Donnell, Aymen Al-Shamkhani, Tobias Kerrinnes, Reneé M Tsolis, Stephen J McSorley
T cell expression of IL-18R and DR3 is essential for non-cognate stimulation of Th1 cells and optimal clearance of intracellular bacteria. PLoS pathogens 13 (8) (2017)